Epithelial-Mesenchymal Transition

 

Epithelial-mesenchymal transition (EMT) is a process whereby largely adherent and polarized epithelial cells acquire the phenotype of more mobile mesenchymal cells. EMT not only facilitates morphogenesis during embryonic development but also promotes invasion and metastasis in tumors. Pathological EMT is associated with E-cadherin repression, which has been shown to contribute to tumor progression. Several oncogenic pathways (e.g., TGF-beta, Wnt/beta-catenin, integrins, and Notch) have been reported to induce EMT via cytoskeleton rearrangement and activation of E-cadherin repressors, including Snail, Slug, SIP1, ZEB1, and TCF3.

 

EMT-inducing Transcription Factors

 

beta Catenin antibody

beta Catenin antibody

SNAI1 antibody

SNAI1 antibody

Twist1/2 antibody

Twist1/2 antibody

     

Epithelial Markers

 

E-Cadherin antibody

E-Cadherin antibody

Cytokeratin 8 antibody

Cytokeratin 8 antibody

Cytokeratin 18 antibody

Cytokeratin 18 antibody

     

Mesenchymal Markers

 

alpha Smooth Muscle Actin antibody

alpha Smooth Muscle Actin antibody

Fibronectin antibody

Fibronectin antibody

N-Cadherin antibody

N-Cadherin antibody